Magrolimab plus rituximab in relapsed/refractory indolent non-Hodgkin lymphoma: 3-year follow-up of a phase 1/2 trial
- Amitkumar Mehta
- , Leslie Popplewell
- , Graham P. Collins
- , Sonali M. Smith
- , Ian W. Flinn
- , Nancy L. Bartlett
- , Nilanjan Ghosh
- , Gal Hacohen-Kleiman
- , Yanan Huo
- , Linda Su-Feher
- , Camille Renard
- , Ranjana Advani
- , Mark Roschewski
Research output: Contribution to journal › Article › peer-review
24
Link opens in a new tab
Scopus
citations